Peter Loo, MD
Sports Medicine · Topeka, KSNPI 1275828535
Payments from drug & device makers
What this record shows
16 manufacturers reported payments, led by Pacira Pharmaceuticals Incorporated at 53.7% of the total. Reporting peaked in 2021 at $1,155 and has fallen 86.1% since, to $161 in 2022. That places this record below the midpoint for sports medicine clinicians in KS, where the typical reported total is $1,653.
Across 56 payments — averaging $29.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$888
- Novo Nordisk$194
- Lilly USA, LLC$152
- AbbVie$124
- Emmaus Medical, Inc.$38
- Amgen$38
- plus $219 from 10 others
What the payments were for
- Travel & lodging$73144%
- Food & beverage$92256%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 5 | $888 |
| Novo Nordisk | 15 | $194 |
| Lilly USA, LLC | 10 | $152 |
| AbbVie | 6 | $124 |
| Emmaus Medical, Inc. | 2 | $38 |
| Amgen | 3 | $38 |
| Stryker(2 entities) | 2 | $34 |
| Amarin Pharma, Inc. | 2 | $30 |
| GSK | 2 | $28 |
| Johnson & Johnson | 2 | $27 |
| Integra Lifesciences Corporation | 1 | $24 |
| Astellas Pharma US Inc | 2 | $22 |
| Biogen | 1 | $18 |
| Boehringer Ingelheim | 1 | $12 |
| Biodelivery Sciences International, Inc. | 1 | $12 |
| Shire North American Group Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IOVERA SYSTEM$731
How this compares
$1,653 in reported general payments places this provider in the 50th percentile of 56 sports medicine providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 288 | $10,305 |
| Diclofenac Sodium | 263 | $3,174 |
| Nabumetone | 72 | $744 |
| Etodolac | 15 | $445 |
| Meloxicam | 111 | $361 |
| Diclofenac Potassium | 13 | $168 |
| Prednisone | 64 | $110 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Topeka
- Ryan TomlinsTopeka$1K
- Hailey AvilaTopeka$99
- Kirk McCulloughLeawood$649K
- Michael KhadaviOverland Park$278K
- James HalloranLeawood$170K
- Scott MullenKansas City$65K
- Kent DoanLeawood$53K
- Daniel ChernoffLeawood$47K
- Erik HenkelmanLawrence$46K
- Brandon BarndsOverland Park$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.